Data, Architectural Engineering, and Designing a Better Future
Proof in Trial: Appellate Edition: Integra Med Analytics LLC et al. v. Providence Health & Services et al.
Compliance Perspectives: The Ethics of Data
Life With GDPR: Episode 50-The Experian Enforcement Notice Case
JONES DAY PRESENTS®: AI: Security and Privacy Risks with Big Data
31 Days to a More Effective Compliance Program -The Compliance Advantage of Data
6 Key Takeaways | The Chinese Social Credit System
Innovation in Compliance Live: Revamping Your Swing with Data Analytics and AI
Podcast: Common Risks and Challenges in Running a Global Ethics & Compliance Program
SEC Activity with Fixed Income and Credit Funds
Innovation in Compliance Episode 17: Compliance in the Age of Big Data with Alexander Tsigutkin and Varun Singhal
The Intersection of Big Data and Insurance Regulation
InsurTech and the Changing Distribution Model
Blockchain Technology Applications for the Insurance Industry
What’s Next?: Drones and transforming policy at GE
Employment Law This Week®: Big Data and People Analytics
Government data mining leads to more aggressive investigations
This Week in FCPA-Episode 74
Episode 23: Using “People Analytics” to Make Smart Business and Corporate Culture Decisions
Changing values of IP and data in deals
On October 22, 2019, Skadden hosted our Ninth Annual Pharmaceutical and Medical Device Enforcement and Litigation Seminar in New York, which focused on U.S. enforcement issues companies face throughout the industry. The key...more
The government is leveraging its access to big data in order to aggressively pursue healthcare investigations. Maria Durant and Gejaa Gobena, partners in our Boston and Washington, D.C. offices, discuss the steps life...more
Often lost in the cacophony of headlines surrounding rising health care costs is the promise that value-based contracting offers as a possible solution. In contrast to the traditional fee-for-service model, value-based...more
Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community, including regular updates on legislative initiatives from AGG’s Washington, DC...more